Scoop has an Ethical Paywall
Centre for Integrated Research in Biosafety
Centre for Integrated Research
in Biosafety
Food regulator should seek more information before approving GM soybeans DP-305423-1
The Centre for Integrated Research in Biosafety (INBI) has made two submissions to Food Standards Australia New Zealand (FSANZ) on their draft recommendation to approve the use of genetically engineered high oleic acid soybeans as human food.
The centre’s Director, Professor Jack Heinemann,
says information contained in the Assessment Report is
insufficient. Prof. Heinemann was the lead author of one of
the submissions.
“FSANZ ignored the costs to consumers
who are attempting to avoid the exposure to this material
even when it is properly labelled. In doing so, they have
probably significantly overstated benefits and understated
consumer costs.”
The INBI team evaluating the FSANZ assessment of application A1018 high oleic acid soybean DP-305423-1 found insufficient information to conclude that this variety of soybean was as safe as conventional soybeans. Heinemann also pointed out that FSANZ had observed potential adverse effects feeding animals other high oleic acid soybeans from the same manufacturer after the soybeans were cooked at temperatures that are similar to how humans would eat soybeans. “Neither in this assessment nor in the previous had those observations been followed up or properly explained” said Prof. Heinemann.
Dr. Brigitta Kurenbach, lead author on the other of the Centre’s submissions, found that key safety tests, particularly characterisation of DNA inserts at undisclosed locations in the genome, and likely new derivative gene products, apparently were not conducted. According to Kurenbach, “what was used as test and control material for all of the different assays was ambiguous and haphazard, making it impossible at this time to have confidence that all potential unintended or unanticipated hazards had been identified for assessment”.
Furthermore, the Assessment report was silent on the possible effects of breathing in soy flour dust, an important pathway to causing potential allergic reactions. Thus the Centre’s researchers were unable to conclude on the available information that high oleic acid soybean DP-305423-1 was as safe as conventional soybean in the range of preparations that are unique to or inseparable from their use as human food.
In addition,
INBI has a general concern about the costs passed on to the
public wishing to exercise their statutory right to engage
in the assessment process. The charges applied by FSANZ to
access the scientific dossier of GM applications are
prohibitive and prevent full and open consultation at least
with this public Centre, and they believe with the public in
general.
INBI is an independent research centre based at
the University of Canterbury that is dedicated to public
good research and assessment of the potential harms and
benefits of genetically modified organisms. INBI in
partnership with GenØk – Centre for Biosafety (Norway)
and Third World Network (Malaysia) produced the Biosafety
Assessment Tool (BAT), a free online resource for citizens,
regulators and researchers wishing to conduct their own
safety assessments (https://bat.genok.org/bat/). The
Centre’s evaluations of the Assessment Report are
available for download from www.inbi.canterbury.ac.nz.
ENDS
Business Canterbury: Urges Council To Cut Costs, Not Ambition For City
Wellington Airport: On Track For Net Zero Emissions By 2028
Landcare Research: ANZAC Gall Fly Release Promises Natural Solution To Weed Threat
NZ Anti-Vivisection Society: Auckland Rat Lovers Unite!
University of Canterbury: $1.35 Million Grant To Study Lion-like Jumping Spiders
Federated Farmers: Government Ends War On Farming
